Angiopoietin-2 in ischemic cardiac patients

Angiopoietin-2 in ischemic cardiac patients

Background: Coronary artery disease (CAD) is the most common cause of death globally according to WHO. Its known that ischemia and cardiac dysfunction promotes the angiogenesis and new vessel formation to compensate for the decreased blood supply through the diseased arteries.Angiopoietin-2(Ang-2) a...

Full description

Bibliographic Details
Main Authors:	Ahmed Magdy Abdelazim*, Mohammed Abdelrazek Elsenbsy, Mohammed H. Hassan, Mohammed AK
Format:	Article
Language:	English
Published:	South Valley University, Faculty of Medicine 2023-07-01
Series:	SVU - International Journal of Medical Sciences
Subjects:	percutaneous coronary intervention (pci) contrast induced nephropathy (cin) angiopoietin-2(ang-2)
Online Access:	https://svuijm.journals.ekb.eg/article_155114.html

Similar Items

Contrast-induced nephropathy in invasive cardiology
by: Tilman N.U. Perrin, et al.
Published: (2012-06-01)

Role of Angiopoietins in Development of Cancer and Neoplasia Associated with Viral Infection
by: Xiaolan Yu, et al.
Published: (2020-02-01)

Cardio- and reno-protective effect of remote ischemic preconditioning in patients undergoing percutaneous coronary intervention. A prospective, non-randomized controlled trial
by: Ayman K.M. Hassan, et al.
Published: (2015-12-01)

Plasma angiopoietin 2 as a novel prognostic biomarker in alcohol-related cirrhosis and hepatitis
by: Victoria Tatiana Kronsten, et al.
Published: (2022-03-01)

Update Overview of the Role of Angiopoietins in Lung Cancer
by: Dimitris Tsakogiannis, et al.
Published: (2021-11-01)

CHA2DS2-VASc, a Simple Clinical Score Expanding Its Boundaries to Predict Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Interventions
by: Kumar R, et al.
Published: (2021-12-01)

Hypertension, renal failure, and edema in a 38-year-old man: light chain deposition disease; a case report and review of the literature
by: Sarmad Said, et al.
Published: (2014-04-01)

Contrast-induced nephropathy; A literature review
by: Jafar Golshahi, et al.
Published: (2014-04-01)

Ultra-low CONtraSt PCI vs conVEntional PCI in patients of ACS with increased risk of CI-AKI (CONSaVE-AKI)
by: Abhinav Shrivastava, et al.
Published: (2022-09-01)

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
by: Ata Firouzi, et al.
Published: (2018-09-01)

The Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction
by: Uğur Özkan, et al.
Published: (2023-03-01)

Contrast Induced Nephropathy
by: Nurul R Ningrum, et al.
Published: (2013-06-01)

Incidence, Risk Factors, and Outcomes of Contrast Associated Nephropathy following Percutaneous Coronary Intervention
by: Iqbal Wani, et al.
Published: (2020-01-01)

Different hydration methods for the prevention of contrast-induced nephropathy in patients with elective percutaneous coronary intervention: a retrospective study
by: Fei Chen, et al.
Published: (2023-06-01)

Prevalence of contrast-induced nephropathy after primary percutaneous coronary intervention at a tertiary referral hospital
by: Zahra Masoomi, et al.
Published: (2024-02-01)

Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease
by: Alessandro Caracciolo, et al.
Published: (2022-04-01)

Risk factor profile, incidence, and relevance of Mehran risk score to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
by: Shahood Ajaz Kakroo, et al.
Published: (2022-01-01)

Original paper<br>Prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary interventions in everyday clinical practice
by: Hanna Bachórzewska-Gajewska, et al.
Published: (2006-12-01)

Persistent Renal Dysfunction in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
by: Kazumasa Kurogi, et al.
Published: (2019-12-01)

Uric acid and contrast-induced nephropathy: an updated review and meta-regression analysis
by: Francesco Pelliccia, et al.
Published: (2018-12-01)

Expression of Angiopoietin 2 in ovarian follicles of crossbred Malabari goat
by: M.S. Adithian, et al.
Published: (2023-03-01)

Predictors of Fibrosis Progression in Chronic Active Hepatitis C Related Nephropathy
by: Amr Shaaban Hanafy, et al.
Published: (2019-05-01)

Acute Kidney Injury After Primary Angioplasty: Is Contrast‐Induced Nephropathy the Culprit?
by: Oren Caspi, et al.
Published: (2017-11-01)

Refining Safe Contrast Limits for Preventing Acute Kidney Injury After Percutaneous Coronary Intervention
by: Neal Yuan, et al.
Published: (2021-01-01)

The relationship between H2FPEF score and contrast induced nephropathy in patients with ST elevation myocardial infarction
by: Ufuk Sadik Ceylan, et al.
Published: (2022-12-01)

Comparative Study of Renal Protective Effects of Allopurinol and N-Acetyl-Cysteine on Contrast Induced Nephropathy in Patients Undergoing Cardiac Catheterization
by: ASHUTOSH KUMAR, et al.
Published: (2014-12-01)

The potential use of Endostatin and Angiopoietin-2 as valuable biomarkers for the prediction of Diabetic Nephropathy in Type 2 Diabetes Mellitus
by: Mohamed Salem, et al.
Published: (2019-12-01)

The predictive value of the prognostic nutritional index for contrast-induced nephropathy
by: Murat Gucun, et al.
Published: (2022-02-01)

Editöre Mektup - Red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention
by: Somsri Wiwanitkit, et al.
Published: (2016-04-01)

Association between the risks of contrast-induced nephropathy after diagnostic or interventional coronary management and the transradial and transfemoral access approaches
by: Ata Firouzi, et al.
Published: (2020-02-01)

Study of saline optical coherence tomography–guided percutaneous coronary intervention (SOCT-PCI Study)
by: Nalin K. Mahesh, et al.
Published: (2020-07-01)

Intravascular Imaging in Ultra-Low or Zero-Contrast Percutaneous Coronary Interventions: The Time Is Now?
by: Kyriakos Dimitriadis, et al.
Published: (2023-12-01)

Remote ischemic preconditioning for prevention of contrast-induced nephropathy – A randomized control trial
by: Akshay Ashok Bafna, et al.
Published: (2020-07-01)

The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome
by: Zheng-rong Xu, et al.
Published: (2019-02-01)

Efficacy of atorvastatin on the prevention of contrast-induced acute kidney injury: a meta-analysis
by: Liu L, et al.
Published: (2018-03-01)

The Development of Robotic Technology in Cardiac and Vascular Interventions
by: Ali Pourdjabbar, et al.
Published: (2017-07-01)

The effect of contrast administration on renal function after cardiac catheterization in Saudi patients
by: Mohammed Ali Balghith
Published: (2019-01-01)

The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study
by: Mateus Paiva Marques Feitosa, et al.
Published: (2023-06-01)

Angiopoietin-2, Renal Deterioration, Major Adverse Cardiovascular Events and All-Cause Mortality in Patients with Diabetic Nephropathy
by: Yi-Chun Tsai, et al.
Published: (2018-04-01)

Prevalence of Periprocedural Complications and Associated Factors of Percutaneous Coronary Intervention in Patients with Ischemic Heart Disease at Coronary Care Units of Tikur Anbessa Specialized Hospital and Gesund Cardiac and Medical Center, Addis Ababa, Ethiopia: A Retrospective Cohort Study
by: Demssis Y, et al.
Published: (2023-09-01)